Cytomegalovirus Diagnostics Market Size, Share, Current Status By Major Key Vendors And Trends By Forecast To 2027

Precision Business Insights published a research report on “Cytomegalovirus Diagnostics Market by Test (Serology, Cell culture, Antigenemia assay, Polymerase Chain Reaction Amplification, Immunohistochemistry, Nucleic acid sequence-based amplification (NASBA), Hybrid capture assay), by Application (Retinitis, Pneumonia, Gastrointestinal Ulcers, Encephalitis, Others), By End-user (Hospitals, Diagnostic Centers, Others) and Geography - Global/Region/Country Forecast to 2027”.

Cytomegalovirus is a double-stranded DNA virus that belongs to the herpesviridae family. This virus primarily causes asymptomatic infections or mild flu-like symptoms, and then remains latent throughout one's life, with the potential to reactivate. As a result, for some people, this virus might be a lifelong companion, while for others, it can be a quiet murderer. The production of such antibodies is defined by cytomegalovirus (CMV) infection, which occurs as a result of the virus's infection, which remains in an individual's body throughout his life. CMV diagnostics are becoming increasingly important for immunocompromised people and pregnant women. Cytomegaloviruses are a leading cause of mental impairment and congenital viral infections in children. In immunocompromised patients, CMV can cause asymptomatic infections, and it can be passed to the foetus during pregnancy from his mother, who may have a primary or recurrent infection. As a result, it is necessary to make an accurate diagnosis of primary infection in the pregnant lady, which can be done using IgG and IgM avidity assays, which are among the most sensitive serological assays, or other molecular and virological procedures for viral identification in blood.

View detailed report description here https://precisionbusinessinsights.com/market-reports/global-cytomegalovirus-diagnostics-market/

Increased rates and prevalence of latent viral infectious diseases, rising need for sophisticated molecular diagnostic tests, and increased public knowledge about these viral infections are all major drivers of the CMV diagnostics market. The rising occurrences and high prevalence of CMV infections in various parts of the world are driving the need for sophisticated diagnostics, which would contribute to the market's growth. Around 65 percent of the population in the United States is infected with CMV, with a frequency of more than 95 percent among those at high risk, such as HIV-positive individuals and unborn newborns of CMV-infected mothers. Many businesses are constantly innovating and developing improved molecular diagnostic tests for CMV infections around the world, which will contribute to the market's future growth.

The Cytomegalovirus Treatment Market is fragmented by Application, which is further divided into Stem Cell Transplantation, Organ Transplantation, Congenital CMV infection, Other Applications. The market is also categorized into Distribution Channel, and Geography.

Geographically, the CMV diagnostics market is dominated by North America, followed by Europe. The well-established healthcare infrastructure in these regions, as well as the high level of awareness and affordability for disease diagnosis and treatment among the people of these regions, are some of the primary factors driving the growth of this market in the region.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=16046

Some of the major key players in the cytomegalovirus diagnostics market are Cell Medical Ltd. (U.K.) Merck & Co. Inc. (U.S.) Chimerix, Inc. (U.S.) Abbott Laboratories (U.S.) Affymetrix, Inc. (U.S.) Becton, Dickinson and Company (U.S.) Bio-Rad Laboratories, Inc. (U.S.) F. Hoffmann-La Roche Ltd.( Switzerland) Johnson and Johnson Services Inc.,(U.S.)

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.